Omicron subvariants BA.4 and BA.5 are spreading further throughout the U.S., according to the Centers for Disease Control and Prevention. The subvariants now make up 13% of COVID-19 cases in the U.S. (The New York Times)

With the federal government low on COVID-19 funds, the Biden administration will reallocate $10 billion from testing and preparedness programs to vaccines and treatments. Some $5 billion will go towards purchasing updated vaccines for the fall, while $4.9 billion will go toward buying 10 million courses of Paxlovid. (Axios)

The FDA has approved the pairing of Foundation Medicine’s companion diagnostic FoundationOne CDx Roche’s ROS1+ cancer drug entrectinib. The tissue biopsy test can pinpoint the “fingerprint” of a tumor. (Endpoints News)

BioNTech is building an mRNA vaccine factory in Rwanda as part of its larger plan to help African nations produce the company’s COVID-19 vaccine. It plans to expand its supply network across other African countries during the next several years. (Reuters)

A study has found a widening disparity in mortality rates across the political spectrum. The study found that people living in areas that tend to vote Democratic had lower age-adjusted mortality rates than people residing in areas that voted Republican. (Kaiser Health News)